Clinical Trials Directory

Trials / Completed

CompletedNCT01109147

Comparison of the Effects of Aripiprazole and Risperidone on the Pattern of Brain Activation in Schizophrenic Patients

Comparison of the Effects of Aripiprazole and Risperidone on the Pattern of Brain Activation in Schizophrenic Patients During Emotional Tasks and With Reference to Controls

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
67 (actual)
Sponsor
Qualissima · Academic / Other
Sex
All
Age
18 Years – 45 Years
Healthy volunteers
Accepted

Summary

After an initial screening visit, including an assessment of psychiatric disorders, patients stabilized on antipsychotic medication (aripiprazole or risperidone) for at least 6 weeks and control subjects will undergo an assessment using functional magnetic resonance imaging (fMRI) of the differences of patterns of brain activation during an emotional task

Detailed description

This study is: interventional, comparative, open label, multi center, without experimental treatment. Main objective: To evaluate the effect of aripiprazole and risperidone on brain activation during an emotional task of matching patients with schizophrenia, and in reference to control subjects. Secondary Objective: Comparison of emotional subjective and physiological perception in patients with schizophrenia in relation with their treatment. Comparison of brain activation in patients during the emotional induction task based on symptomatic dimensions, personality traits and performance on cognitive and attentional tests, and for insight capacity . Comparison of transcript level of candidate genes in blood mononuclear cells between the study groups and study the interactions between the observed differences in brain imaging and different levels of transcription of these genes.

Conditions

Interventions

TypeNameDescription
OTHERImageryAll the subject will be submitted to an functional magnetic resonance imaging (fMRI) examination.
GENETICpharmacogenetic samplingA pharmacogenetic sample will be done with an additional consentment.

Timeline

Start date
2010-12-01
Primary completion
2013-01-01
Completion
2013-05-01
First posted
2010-04-23
Last updated
2014-04-09
Results posted
2014-04-09

Locations

2 sites across 1 country: France

Source: ClinicalTrials.gov record NCT01109147. Inclusion in this directory is not an endorsement.